Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 3Breast 2Tumor-Agnostic 1Other 1Gynecologic 1

Conditions

Breast Neoplasms 2Intermittent Fasting 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Diet, Healthy × Breast × Clear all
NCT01525264 2016-08-18

Breast Cancer Screening Intervention

Jonsson Comprehensive Cancer Center

Phase NA Completed
434 enrolled
Breast

Breast Neoplasms

NCT01304251 2016-01-12

Effects of Short-term Fasting on Tolerance to Chemotherapy

Leiden University Medical Center

Phase NA Completed
13 enrolled
Breast

Intermittent Fasting, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡